share_log

SomaLogic (NASDAQ:SLGC) Shares Gap Down to $3.00

SomaLogic (NASDAQ:SLGC) Shares Gap Down to $3.00

納斯達克(Sequoia Capital：SLGC)股價下跌至3美元
Defense World ·  2022/09/28 04:42

SomaLogic, Inc. (NASDAQ:SLGC – Get Rating) gapped down before the market opened on Monday . The stock had previously closed at $3.00, but opened at $2.89. SomaLogic shares last traded at $2.96, with a volume of 15,629 shares.

週一開盤前，SomaLogic公司(納斯達克代碼：SLGC-GET Rating)股價下跌。該股此前收於3.00美元，但開盤報2.89美元。SomaLogic的股票最新報2.96美元，成交量為15,629股。

Analyst Ratings Changes

分析師評級發生變化

A number of brokerages have recently commented on SLGC. Cowen lowered their price target on shares of SomaLogic from $11.00 to $9.00 and set an "outperform" rating for the company in a report on Tuesday, August 16th. Cowen lowered their price target on shares of SomaLogic from $11.00 to $9.00 in a report on Tuesday, August 16th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, SomaLogic has a consensus rating of "Buy" and an average price target of $13.33.

多家券商近期紛紛對SLGC發表評論。考恩在8月16日週二的一份報告中將SomaLogic的股票目標價從11.00美元下調至9.00美元，併為該公司設定了“跑贏大盤”的評級。考恩在8月16日星期二的一份報告中將SomaLogic的目標股價從11.00美元下調至9.00美元。根據MarketBeat.com的數據，五位研究分析師將該股的評級定為買入，SomaLogic的普遍評級為買入，平均目標價為13.33美元。

Get
到達
SomaLogic
SomaLogic
alerts:
警報：

SomaLogic Stock Up 2.4 %

SomaLogic股價上漲2.4%

The company has a market cap of $544.86 million, a PE ratio of -3.58 and a beta of 1.53. The business's 50 day moving average price is $4.14 and its 200-day moving average price is $5.43.

該公司市值為5.4486億美元，市盈率為-3.58，貝塔係數為1.53。該業務的50日移動均線價格為4.14美元，其200日移動均線價格為5.43美元。

Institutional Trading of SomaLogic

SomaLogic的機構交易

A number of hedge funds have recently made changes to their positions in SLGC. Vanguard Group Inc. raised its stake in shares of SomaLogic by 158.1% during the first quarter. Vanguard Group Inc. now owns 6,473,890 shares of the company's stock valued at $51,921,000 after purchasing an additional 3,965,138 shares during the period. Point72 Asset Management L.P. increased its stake in shares of SomaLogic by 190.2% in the fourth quarter. Point72 Asset Management L.P. now owns 3,720,666 shares of the company's stock worth $43,309,000 after buying an additional 2,438,734 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of SomaLogic by 2,913.7% in the first quarter. Goldman Sachs Group Inc. now owns 2,120,772 shares of the company's stock worth $17,009,000 after buying an additional 2,050,401 shares during the last quarter. State Street Corp increased its stake in shares of SomaLogic by 403.9% in the second quarter. State Street Corp now owns 2,510,507 shares of the company's stock worth $11,347,000 after buying an additional 2,012,256 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. bought a new stake in shares of SomaLogic in the second quarter worth $8,922,000. Hedge funds and other institutional investors own 59.29% of the company's stock.
一些對衝基金最近改變了他們在SLGC的頭寸。先鋒集團第一季度增持SomaLogic股份158.1%。先鋒集團目前持有該公司6,473,890股股票，價值51,921,000美元，在此期間又購買了3,965,138股。Point72Asset Management L.P.在第四季度增持了SomaLogic的股份190.2%。Point72 Asset Management L.P.在上個季度額外購買了2,438,734股後，現在擁有3,720,666股該公司股票，價值43,309,000美元。高盛股份有限公司在第一季度增持了SomaLogic股份2,913.7%。高盛股份有限公司在上個季度增持了2,050,401股後，目前持有該公司2,120,772股股票，價值17,009,000美元。道富集團在第二季度增持了SomaLogic的股份403.9%。道富銀行目前持有2,510,507股該公司股票，價值11,347,000美元，此前該公司在上一季度又購買了2,012,256股。最後，三井住友信託控股有限公司(Sumitomo Mitsui Trust Holdings Inc.)在第二季度購買了價值892.2萬美元的SomaLogic新股。對衝基金和其他機構投資者持有該公司59.29%的股票。

SomaLogic Company Profile

SomaLogic公司簡介

(Get Rating)

(獲取評級)

SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.

SomaLogic公司在美國是一家蛋白質生物標記物發現和臨牀診斷公司。它開發慢速修飾適體(SOMAmers)，這是一種針對其同源蛋白質的改良核酸蛋白質結合試劑；並提供專有的SomaScan服務，提供複雜生物樣本中的多重蛋白質檢測和蛋白質水平的量化。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on SomaLogic (SLGC)
  • Defensive Stocks For A Volatile Market
  • Will UPS Be Next to Deliver a Warning?
  • SunPower Is Ready To Power Up Triple-Digit Earnings Gains
  • Is This the Darkest Before the Dawn for Gap Stock?
  • Build A Better Tech Portfolio With Jabil Inc.
  • 免費獲取StockNews.com關於SomaLogic的研究報告(SLGC)
  • 防禦性股票應對動盪的市場
  • UPS會成為下一個發出警告的公司嗎？
  • SunPower準備推動三位數的收益增長
  • 這是Gap Stock黎明前最黑暗的一次嗎？
  • 與捷普公司一起打造更好的技術產品組合。

Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with MarketBeat.com's FREE daily email newsletter.

接受SomaLogic日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對SomaLogic和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論